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Abstract
Adducins tightly regulate actin dynamics which is critical for endothelial barrier function.
Adducins were reported to regulate epithelial junctional remodeling by controlling the as-
sembly of actin filaments at areas of cell-cell contact. Here, we investigated the role of α-
adducin for endothelial barrier regulation by using microvascular human dermal and myo-
cardial murine endothelial cells. Parallel transendothelial electrical resistance (TER) mea-
surements and immunofluorescence analysis revealed that siRNA-mediated adducin
depletion impaired endothelial barrier formation and led to severe fragmentation of VE-
cadherin immunostaining at cell-cell borders. To further test whether the peripheral localiza-
tion of α-adducin is functionally linked with the integrity of endothelial adherens junctions,
junctional remodeling was induced by a Ca2+-switch assay. Ca2+-depletion disturbed both
linear vascular endothelial (VE)-cadherin and adducin location along cell junctions, whereas
their localization was restored following Ca2+-repletion. Similar results were obtained for α-
adducin phosphorylated at a site typical for PKA (pSer481). To verify that endothelial barrier
properties and junction reorganization can be effectively modulated by altering Ca2+-
concentration, TERmeasurements were performed. Thus, Ca2+-depletion drastically re-
duced TER, whereas Ca2+-repletion led to recovery of endothelial barrier properties result-
ing in increased TER. Interestingly, the Ca2+-dependent increase in TER was also
significantly reduced after efficient α-adducin downregulation. Finally, we report that inflam-
matory mediator-induced endothelial barrier breakdown is associated with loss of α-adducin
from the cell membrane. Taken together, our results indicate that α-adducin is involved in
remodeling of endothelial adhesion junctions and thereby contributes to endothelial
barrier regulation.
Introduction
The vascular endothelium lining the inner surface of blood vessels precisely controls the pas-
sage of solutes, macromolecules, plasma proteins and inflammatory mediators and therefore
provides a selective barrier between the blood and the surrounding tissue. Under inflammatory
conditions, mainly in post-capillary venules, breakdown of the endothelial barrier function
causes formation of intercellular gaps and enhanced vascular permeability. The latter results in
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severe subcutaneous and whole body cavity edema, which is the major risk factor for organ fail-
ure and death [1–4]. Therefore, our efforts are directed towards better understanding the
mechanism underlying endothelial barrier integrity.
The endothelial barrier consists of two main types of intercellular junctions, i.e. tight junc-
tions (TJs), sealing the intercellular cleft between neighboring cells, and the mechanical
strength-providing adherens junctions (AJs). Those junctions are properly linked to the mem-
brane-associated cortical actin cytoskeleton via their adaptor molecules and therefore may
tightly control paracellular permeability [5]. Besides, the association of TJs and AJs with the
actin cytoskeleton may explain why intracellular signaling regulating actin dynamics is critical
for endothelial barrier function. In this line of thought, our previous study revealed that F-
actin stabilization enhances barrier function whereas both depolymerization and hyperpoly-
merization of F-actin reduces endothelial barrier properties in vitro and in vivo [6]. The process
of actin polymerization was shown to be tightly regulated by actin-binding proteins such as va-
sodilator-stimulated phosphoprotein (VASP) [7], cortactin [8] and adducins [9]. While the es-
sential role of VASP and cortactin in regulation of endothelial barrier function has already
been partly determined [3], to our best knowledge, the role of adducins in this process is
largely unknown.
Adducins are a family of membrane skeletal proteins comprised of three closely related
polypeptide isoforms encoded by distinct genes (α, β, and γ). While α- and γ-adducins are
ubiquitously expressed in most tissues, the β isoform has a more restricted tissue distribution
pattern [10]. As actin-binding proteins and key regulators of the actin polymerization process,
adducins have been shown to play an essential role in maintenance of plasma membrane stabil-
ity, cell-cell contact formation and regulation of cell motility [11]. In line with this, it was re-
cently proposed that stable formation of AJs can be initiated by homophilic interaction
between E-cadherins, followed by recruitment of ß-catenin and assembly of F-actin at epitheli-
al cell-cell junctions. Once assembled at cell-cell junctions, F-actin recruits adducin which con-
sequently links spectrin to F-actin and thus stabilizes the structure of cell-cell junctions [12].
Besides mediating spectrin-F-actin linkage, adducins are also reported to regulate actin fila-
ment bundling and capping. Additionally, it was recently demonstrated that downregulation of
adducin attenuates formation of perijunctional F-actin bundles during reestablishment of epi-
thelial AJs [13]. Moreover, a recent study from our group showed that silencing of adducin
leads to considerable disruption of the actin cytoskeleton accompanied by impaired desmo-
some formation [14]. It was also shown that Rac1-deficient erythrocytes revealed defective as-
sociation of the actin—spectrin scaffold and this was accompanied by changes in adducin
phosphorylation [15]. In this respect, numerous reports demonstrated various functional con-
sequences of adducin phosphorylation by different kinases. For instance, Rho-kinase phos-
phorylates adducin and thereby enhances its F-actin-binding activity in vitro. In contrast,
protein kinase A (PKA)- and protein kinase C (PKC)-promoted adducin phosphorylation
leads to opposite effects, i.e. reduced adducin binding activity to F-actin and to the F-actin-
spectrin complex as well as to attenuation of spectrin recruitment to F-actin [16–18]. Adducin
was also found to be rapidly removed from intercellular junctions and degraded in response to
cytokines, invading bacteria and proapoptotic agents. Therefore, it was speculated that dys-
function of adducin can mediate disruption of epithelial barrier during infection and inflam-
mation [13].
In the present study we examined the role of α-adducin in the formation and modulation of
endothelial junctional integrity by using two different microvascular endothelial cell lines.
Herein, we report that silencing of adducin not only negatively affects endothelial barrier for-
mation but also modified Ca2+-dependent barrier reassembly. Moreover, we showed that in en-
dothelial monolayers treatment with inflammatory mediators such as lipopolysaccharide
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(LPS), thrombin and tumor necrosis factor alpha (TNFα) resulted in loss of membrane-
associated α-adducin.
Materials and Methods
Cell culture and antibodies used
Human Dermal Microvascular Endothelial Cells (HDMEC), the corresponding maintaining
media and the Detach kit for further cell passaging were purchased either from PromoCell
(Heidelberg, Germany) or from Lonza (Switzerland). The experiments were conducted with
cells at passages 2 to 5 [19]. In addition, immortalized microvascular endothelial cells
(MyEnd), previously isolated from murine myocardial tissue were used. MyEnd generation
and characterization have been described elsewhere [20, 21]. Cells were grown in DMEM (Life
Technologies, Karlsruhe, Germany), supplemented with Penicillin G/Streptomycin (50 U/ml)
(Sigma-Aldrich, Munich, Germany) and 10% Fetal Calf Serum (FCS) (Biochrom, Berlin, Ger-
many). Both cell types were cultured at 37°C in a humidified atmosphere of 5% CO2.
Vascular endothelial (VE)-cadherin in HDMEC was detected with goat anti-VE-cadherin
pAb, purchased from Santa Cruz Biotechnology (Santa Cruz, U.S.A.). In MyEnd, VE-cadherin
was immunolabeled with anti-VE-cadherin mAb (clone 11D4.1; undiluted hybridoma). For
Western blot and immunofluorescence analyses in MyEnd cells, anti-α-adducin pAb (Abcam,
Cambridge, United Kingdom) was applied. Primary anti-α-adducin mAb (Santa Cruz, Dallas,
Texas, USA) was used for immunofluorescence staining in HDMEC. For visualization of α-
adducin phosphorylated at Ser481, anti-α-adducin Ser481 mAb (Abcam, Cambridge, United
Kingdom) was selected. Anti- γ-adducin (D11) mAb from Santa Cruz was used for immuno-
blot detection of γ-adducin. To observe proteins used as a loading control anti-α-tubulin mAb
(Abcam, Cambridge, United Kingdom) and/or anti-ß-actin mAb obtained from Sigma-Aldrich
(Munich, Germany) were utilized. Fluorescence monitoring of filamentous actin (F-actin) was
achieved by using Alexa Fluor 488 phalloidin dye (Life Technologies, Karlsruhe, Germany).
Nuclear morphology was controlled by direct labeling of the DNA with 4’,6-diamidino-
2-phenylindole dihydrochloride (DAPI) (Roche Applied Science, Basel, Switzerland).
Test reagents
Similarly to previous studies, an inflammatory mediator such as lipopolysaccharide (LPS) from
Escherichia coli O111:B4 (Sigma-Aldrich, Munich, Germany, L2630) was used for 4 hours at
100 ng/ml. Human thrombin (Sigma-Aldrich, Germany) was applied at 10 U/ml for 5 min.
Cell monolayers were incubated for 2 hours with 100 ng/ml of Tumor Necrosis Factor alpha
(TNFα) (Biomol, Hamburg, Germany).
Transfection with Small Interfering RNA (siRNA)
Significant transient down-regulation of α-adducin was achieved by adducin-specific
ON-Target SMARTpool small interfering RNA (siRNA). Parallel transfection with a pool of
ON-TARGET plus Non-Targeting (n.t.) siRNAs served as a negative control. The pools of
siRNA sequences were obtained from Dharmacon, Waltham, U.S.A. To deliver the siRNA into
the cell, TurboFect in vitro transfection reagent (Fermentas, St. Leonrot, Germany) was ap-
plied. The transfection was carried out according to the manufacturer’s instructions in cell
monolayers at 70–80% confluency.
Permeability properties of transiently silenced MyEnd cell monolayers were monitored by
TER-based measurements, which were started 24 or 48 hours after initial transfection and sub-
sequent medium exchanged.
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Immunofluorescence analysis
HDMEC and MyEnd endothelial cells were grown to confluency on uncoated and gelatin-
coated glass cover slips, respectively. As previously described [22], control and treated cell
monolayers were fixed for 10 min at room temperature (RT) with freshly prepared 2% formal-
dehyde in PBS. Cells were washed with PBS and permeabilized with 0.1% Triton X-100 in PBS
at RT. After rinsing with PBS, the adherent cell monolayer was blocked for 1 hour with 10%
normal goat or donkey serum and 1% BSA in PBS. Incubation with primary antibodies (1:100
of each in PBS) was performed overnight at 4°C. After several washing steps with PBS, cell
monolayers were treated with respective secondary antibodies conjugated with Cy3 or Cy2
(1 hour, RT). For visualization of filamentous actin, Alexa Fluor 488- conjugated—phalloidin
was added to the secondary antibody at 1:100 dilution. Similarly, DAPI was applied to visual-
ize nuclear morphological changes. Cell monolayers were photographed with a confocal mi-
croscope (Leica SP5, Mannheim and Wetzlar, Germany) equipped with a HCX PL APO
Lambda blue 63× 1.4 oil immersion objective (Leica). The same microscope settings were used
for all conditions tested.
Protein extraction andWestern blot analysis
Endothelial cells were grown to confluency. After quick washing with ice-cold PBS, cells were
lysed with SDS-lysis buffer (25 mMHEPES, 2 mM EDTA, 25 mMNaF and 1% SDS) supple-
mented with protease inhibitor cocktail (Roche, Germany). Cells were scraped and the suspen-
sion was sonicated. Protein concentration was estimated using a BCA protein assay kit (Pierce/
Thermo Scientific, Waltham, Germany). Lysates were subjected to gel electrophoresis and the
blots were probed with the desired antibodies.
Transendothelial electrical resistance (TER) measurement
To assess the endothelial barrier integrity of confluent cell monolayers, an ECIS Z Theta system
(Applied Biophysics Inc, Troy, New York, U.S.A.) was used as previously described [22]. In
brief, HDMEC and MyEnd cells were grown to confluency on uncoated and gelatin-coated
gold microelectrodes 8W10E+ (Ibidi, Martinsried, Germany), respectively. Shortly before the
experiment, the medium was exchanged and the microelectrodes were mounted onto the hold-
ers of the ECIS system, and incubated at 37°C and humidity of 5% CO2. All TER measurements
were recorded at 4000 Hz, the experimentally determined optimal frequency for monitoring
changes in the transednothelial resistance. After a short equilibration period of approximately
20 to 30 minutes, the baseline resistance was recorded.
Calcium switch assay
For the calcium switch assay, endothelial cells were grown to confluency (vehicle) and then
treated for 1 hour with 2.5 mM EGTA in a medium containing 50% of the supplements (Ca2+-
depletion). In order to perform Ca2+-repletion, 5 mM CaCl2 was added for 8 hours.
Data analysis
Data is expressed as mean ± SEM. Data analysis was carried out with Prism Software version 5
(Graph Pad, San Diego, California, U.S.A.). While 2-tailed paired Student’s t-test was used to
compare two groups, One-way Analysis of Variance (ANOVA) followed by a Bonferroni's
Multiple Comparison Test was applied to determine the differences among three groups. The
results were considered statistically significant at p 0.05.
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Results
α- and γ-adducin isoforms are abundant in microvascular endothelial
cells
The expression levels of α- and γ-adducin in endothelial cell models were examined by West-
ern blot. Expression of both adducin isoforms was stronger in HDMEC than in MyEnd cells
(Fig 1A and 1B). In both cell lines, α-adducin was detected at some segments of the cell mem-
brane where it colocalized with VE-cadherin and claudin-5 under control conditions (Fig 1C
and 1F, arrows). In HDMECs, cytoplasmic distribution was also observed whereas MyEnd
cells displayed nuclear staining. Since the isotype controls and the secondary antibodies alone
did not show pronounced unspecific staining of nuclei or cytoplasm, the observed α-adducin
signals were most likely caused by the anti-α-adducin antibody (S1 and S2 Figs).
α-adducin contributes to endothelial barrier formation by affecting
adherens junction formation
To study the role of α-adducin in endothelial barrier formation and maintenance, down-
regulation of endogenous α-adducin was induced by a siRNA approach applied in subconflu-
ent MyEnd cells. Endothelial cells transfected with non-target (n.t.) siRNA were used as
a control.
α-adducin downregulation was confirmed by Western blot analysis where significant de-
crease in the expression of α-adducin was demonstrated 48 hours after initial siRNA applica-
tion. Depletion was less prominent 72 hours after siRNA-specific transfection (Fig 2A and 2B).
Protein deficiency was further verified by immunofluorescence. Immunolabeling showed sig-
nificant reduction of α-adducin staining along cell-cell contacts (Fig 2C and 2D). This was ac-
companied by considerable disorganization and fragmentation of VE-cadherin localization.
No changes in nuclear morphology were found by DAPI staining (Fig 2C and 2D). These re-
sults were used to determine the time course for subsequent TER measurements. The latter
were initiated one day after siRNA transfection and subsequent medium exchanged. TER mea-
surements were run for at least 24 hours (Fig 2E) and the effect of α-adducin depletion on en-
dothelial barrier formation and maintenance was monitored. In control monolayers TER
increased with time and reached maximal values approximately 48 hours after transfection
(1500 min: 106.7 ± 1.7% of baseline). In contrast, TER of α-adducin deficient cells did not in-
crease (1500 min: 87.1 ± 4% of baseline).
α-adducin localization at cell-cell junctions parallels integrity of adherens
junctions (AJs)
Recent studies revealed that adducins are localized at epithelial cell-cell junctions where they
specifically colocalize with junctional E-cadherin [12, 23]. In endothelial cells, vascular endo-
thelial (VE)-cadherin is the main adhesive molecule of intercellular AJs. VE-cadherin mediates
Ca2+-dependent homophilic interaction responsible for adhesion of endothelial cells and for-
mation of a confluent monolayer and the endothelial barrier [24]. Therefore, to further test
whether the peripheral localization of α-adducin is linked with integrity of VE-cadherin-based
AJs and endothelial barrier function, endothelial junctional remodeling was induced by a Ca2+
switch assay. The latter involves removal of extracellular Ca2+ (Ca2+-depletion) to trigger disas-
sembly of already formed AJs. In contrast, subsequent Ca2+ re-addition (Ca2+-repletion) in-
duces recovery of junctional structure and function [25]. Thus, in order to test whether the
junction reorganization in response to Ca2+ switch can effectively modulate endothelial barrier
properties, TER measurements in HDMEC (Fig 3A) and MyEnd cells (Fig 3B) were performed.
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Fig 1. α- and γ-adducins are expressed in microvascular endothelium and α-adducin is colocalized
with junctional proteins. (A) Protein abundance of α- and γ-adducins was evaluated byWestern blot. α-
tubulin or ß-actin were used to control for equal gel loading. (B) Expression profile of both adducin isoforms in
bar graph representing the signal intensity analyzed by densitometry and normalized to the protein level of
the respective loading control (Means ± SEM). In comparison to MyEnd cells, HDMEC cells showed
significantly higher expression of α- and γ-adducins in total cell lysates (*P<0.05, **P<0.01, paired t-test,
2-tails) (C-F) Dual immunostaining for α-adducin with either AJ or TJ proteins in HDMEC and MyEnd cells
revealed colocalization of α-adducin with VE-cadherin (AJ) and claudin-5 (TJ), respectively. The results are
representative of three or more independent experiments. Scale bar = 20 μm.
doi:10.1371/journal.pone.0126213.g001
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Fig 2. siRNA-mediated α-adducin knockdown significantly impaired endothelial barrier formation and
caused loss of VE-cadherin from AJs. (A) Knockdown efficiency in MyEnd was confirmed byWestern blot
48 hours and 72 hours after treatment with α-adducin-specific siRNAs. Cell monolayers exposed to non-
target siRNA (n.t. siRNA) were used as a control. Equal gel loading was confirmed by α-tubulin or ß-actin (B)
Bar graph shows densitomertic analysis of the respective blots, ***p 0,0001, significance from control (n.t.
siRNA), One-way.ANOVA. (C-D) Further evaluation of the depletion efficiency was achieved by
immunofluorescence analysis. Double staining for simultaneous detection of α-adducin (red) and junctional
Adducin in Endothelial Barrier Regulation
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For that purpose, microvascular endothelial cells were grown to confluency in medium con-
taining 100% of supplements. During Ca2+-depletion, cells were treated with 2.5 mM EGTA
for 1 hour in medium with 50% supplements (indicated by first arrow in Fig 3A and 3B). Ca2
+-repletion was performed by re-addition of CaCl2 to a final concentration of 5 mM for 8
hours (second arrow in Fig 3A and 3B). The analysis revealed that as a result of Ca2+-depletion
TER was drastically reduced in both cell lines, whereas Ca2+-repletion led to recovery of endo-
thelial barrier properties with different time courses. In MyEnd cells TER values were similar
to controls from 300 min on and were not significantly different after 900 min (Fig 3B). In
HDMEC monolayers barrier reformation was slower (Fig 3A), which may be caused by the
more prominent decrease in TER immediately after EGTA application (Ca2+-depletion).
Furthermore, HDMEC and MyEnd cell monolayers subjected to Ca2+-switch were immu-
nostained for VE-cadherin and α-adducin as well as labeled for F- actin using Alexa 488-phal-
loidin. In order to verify normal nuclear morphology, nuclei were stained with DAPI.
Moreover, since α-adducin is a substrate of protein kinase A (PKA), a molecule implicated in
cAMP-mediated endothelial barrier stabilization [26], endothelial cell monolayers were co-
stained for α-adducin phosphorylated at a site typical for PKA (α-adducin pSer481). Under
control conditions the continuous VE-cadherin distributions was paralleled with pronounced
membrane localization of α-adducin. Distribution of α-adducin pSer481 resembled the pattern
of α-adducin as described above with the only difference that in MyEnd cells almost all cells
displayed membrane localization (Fig 3C and 3F, arrows). Depletion of Ca2+ resulted in severe
VE-cadherin dissociation from AJs, accompanied by pronounced disruption of α-adducin and
α-adducin pSer481-localization along the cell periphery (Fig 3D and 3J). Additionally, reduc-
tion of F-actin staining and considerably increased gap formation was observed (Fig 3D and 3J,
arrowheads). However, replacement of Ca2+ not only increased the staining of intracellular F-
actin, but also restored the distribution of VE-cadherin, α-adducin and α-adducin pSer481 at
cell-cell borders (Fig 3E–3H, stars). In contrast, DAPI staining revealed no morphological
changes of nuclei under all conditions.
Depletion of α-adducin impaired Ca2+-dependent endothelial junction re-
assembly
We next analyzed whether α-adducin is essential for reestablishment of Ca2+-dependent endo-
thelial barrier integrity by using Ca2+-switch model in cell monolayers depleted for α-adducin
for 48 hours as described above (Fig 4). In comparison to control monolayers, adducin-depleted
cells showed a significant and stable reduction in TER when re-exposed to extracellular Ca2+.
No significant differences in TER were monitored in Ca2+- depleted monolayers transfected
with either n.t or adducin-specific siRNA. Moreover, cells transfected with n.t. siRNA recovered
following Ca2+- repletion and were not statistically different from untreated monolayers. In
contrast, Ca2+-repleted, adducin-deficient monolayers did not completely recover barrier func-
tion. Taken together, these results confirm the prominent role of α-adducin in the modulation
of Ca2+-dependent endothelial barrier reorganization.
VE-cadherin (green) was performed. (C) While significant α-adducin and VE-cadherin membrane staining
was monitored under n.t. siRNA conditions, (D) target- specific knockdown led to a substantial reduction of α-
adducin staining along cell borders. The effect was paralleled by severe disruption of VE-cadherin staining.
Nuclei were visualized with DAPI (blue). Scale bar = 20 μm. (E) TERmeasurements in subconfluent, α-
adducin depleted MyEnd cell monolayers revealed significant impairment of barrier formation 500 min after
initial monitoring. Cells transfected with n.t. siRNA were used as a control. Data are representative of three or
more independent experiments. *p 0.05 shows statistically significant difference between monolayers
exposed to n.t and α-adducin specific siRNAs.
doi:10.1371/journal.pone.0126213.g002
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Fig 3. α-adducin accumulation along cell junctions paralleled AJ reorganization. Integrity and structural
alterations in endothelial cell monolayers, subjected to a Ca2+-switch assay, were further evaluated either by
TERmeasurements or by immunofuorescence analysis. (A-B) Time course of mean TER values showed that
Ca2+-depletion (indicated by first arrow) induced a significant drop in TER which was largely recovered by
Ca2+-repletion (second arrow) in HDMEC (A) and MyEnd (B) cells. *p 0.05 difference between control cells
and cells depleted of Ca2+. Immunofluorescence analysis in HDMEC (C-E) and MyEnd cells (F-H) was
performed. After subsequent fixation and permeabilization, cell monolayers were stained for VE-cadherin, α-
Adducin in Endothelial Barrier Regulation
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Endothelial barrier breakdown induced by inflammatory mediators is
paralleled with remarkable reduction of α-adducin and α-adducin
(pSer481) at cell junctions
Finally, we sought whether the localization of α-adducin at cell junctions also parallels endothe-
lial barrier dysfunction under inflammatory conditions. Thus, HDMEC monolayers were
adducin and α-adducin (pSer481). Additionally, Alexa Fluor 488 phalloidin was used for staining of F-actin.
To identify the nuclei, cells were counterstained for DAPI (blue). (C and F) Immunofluorescence in HDMEC
(C) and MyEnd cells (F) revealed that under control condition, in parallel to VE-cadherin, α-adducin and α-
adducin (pSer481) are markedly localized along cell-cell borders (arrows). (D and J) In both cell lines Ca2
+-depletion led to irregular (arrows) or absent VE-cadherin staining, associated with reduced localization or
complete absence of α-adducin and α-adducin (pSer481) at cell-cell-junctions. This was accompanied with
reduced staining of F-actin and induced intercellular gap formation (arrowhead). (E and H) In contrast,
repletion of Ca2+ restored linear VE-cadherin staining as well as accumulation of α-adducin and α-adducin
(pSer481) at cell-cell borders (stars). The staining of F-actin was increased as well. For all conditions, no
morphological changes in the nuclei were observed. Images are representative of three or more independent
experiments. Scale bar = 20 μm.
doi:10.1371/journal.pone.0126213.g003
Fig 4. Depletion of α-adducin attenuates Ca2+-mediated recovery of junctional integrity. Endothelial barrier integrity of monolayers transiently
transfected with α-adducin siRNA and subjected to Ca2+-switch assay was examined by TER. Cells treated with n.t siRNA were used as control. Time course
of mean TER values showed that endothelial barrier recovery was significantly attenuated in adducin-depleted monolayers re-exposed to Ca2+ (Ca2
+-repletion) when compared to control monolayers transfected either with n.t. or adducin-specific siRNA. In parallel, treated with n.t. siRNA and re-exposed to
extracellular Ca2+ monolayers, displayed resistance quite similar to vehicle monolayers. Data were collected from three independent experiments. *p 0.05
indicates difference between TERmonitored in α-adducin siRNA-Ca 2+-repletion and n.t siRNA-vehicle. +p 0.05 indicates difference between TER
monitored in α-adducin siRNA- Ca 2+-repletion and α-adducin siRNA-vehicle; n.s.- denotes p 0.05.
doi:10.1371/journal.pone.0126213.g004
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treated with different barrier-disruptive mediators such as LPS (4 hours), thrombin (5 min) and
TNFα (2 hours). As previously published [19, 27, 28], TER measurements of mediator-treated
HDMEC confirmed the effective endothelial barrier breakdown induced by LPS, thrombin and
TNFα (Fig 5A). Subsequent immunostaining for VE-cadherin, α-adducin and α-adducin
(pSer481) as well as direct staining of F-actin and DAPI was performed. Under control condi-
tions, VE-cadherin and both adducin forms were distributed at cell borders as described above.
Untreated monolayers also displayed relatively few stress fibers visualized by F-actin staining
(Fig 5B). In contrast, drastically increased stress fiber formation, paralleled with severe VE-
cadherin interdigitation and pronounced gap formation (arrowheads) was monitored under
LPS, thrombin or TNFα- treatment. These morphological changes were associated with signifi-
cant loss of both α-adducin and α-adducin (pSer481) junctional staining (Fig 5C–5E). Nuclear
staining with DAPI demonstrated intact cell nuclei under all conditions (Fig 5B–5E).
Discussion
Besides being key regulators of actin polymerization process, adducins are also reported to con-
trol cell migration and cell-cell-contact formation [9, 29]. In respect to the latter, several studies
reported the association of adducins with intercellular contacts in epithelia [9, 23, 30]. More
specifically, a study of Naidenov et al., demonstrated the role of α- and γ- adducin isoforms in
the modulation of tight and adhesion junctions [13]. It was reported recently that adducin is
crucial for keratinocyte cohesion [14], which is in line with data suggesting that α-adducin de-
pletion impairs E-cadherin- mediated adhesion of MDCK cells [12]. However, although the
study of Cappuzzello et al., demonstrated that α-adducin contributes to the regulation of endo-
thelial function in hypertension in vitro and in vivo [31], hardly anything is known about the
role of adducins in formation and maintenance of endothelial barrier integrity. Thus, our study
provides the first evidence that α-adducin is implicated in formation of endothelial barrier in-
tegrity and is involved in modulation of Ca2+-dependent AJ reorganization. Similar to the
study of Chen and co-workers [12] we demonstrated that prevention of VE-cadherin homo-
phylic interaction by Ca2+-depletion impairs the recruitment of α-adducin to cell-cell contacts.
In contrast, Ca2+readdition restored both VE-cadherin homophylic interaction and accumula-
tion of α-adducin and α-adducin (pSer481) at cell-cell-junction, suggesting that the recruit-
ment of α-adducin to the junctions as well as its phosphorylation status may also be important
for the stability of VE- cadherin interaction.
Adducins were reported to be substrates of PKA, PKC and Rho kinase [16–18, 29], however
the role of adducin phosphorylation in endothelial cells is not clear yet. While cAMP/PKA-me-
diated signaling is well known to strength endothelial function [32, 33], other studies in non-
endothelial tissues showed that PKA- and PKC-promoted adducin phosphorylation leads to
reduced adducin binding to F-actin and to the F-actin-spectrin complex as well as promotes at-
tenuation of spectrin recruitment to F-actin [16–18], which was shown to contribute to
enchanced remodeling of the cortical cytoskeleton and destabilization of cell-cell contacts [25].
Since our previous studies indicate that cAMP-mediated signaling is impaired under inflam-
matory conditions [19, 27, 28], we investigated whether junctional localization of adducin
(pSer481) is affected by inflammatory mediators. Similarly to the Ca2+-switch assay, we found
that endothelial barrier breakdown induced by LPS, thrombin or TNFα was associated with
loss of α-adducin and α-adducin (pSer481) from cell junctions. However, more detailed inves-
tigations are necessary to provide deeper insight into the role of adducin phosphorylation in
endothelial barrier regulation.
Furthermore, although studies on α-adducin-null mice did not report specific abnormalities
in vascular integrity, the dynamic role for adducin in assembly, maintenance and regulation of
Adducin in Endothelial Barrier Regulation
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Fig 5. Changes in adducin localization parallel to endothelial barrier dysfunction induced by
inflammatory mediators. Barrier integrity of HDMEC control monolayers and monolayers exposed to
different inflammatory mediators such as thrombin, LPS and TNFα was evaluated by TERmeasurements
and immunofluorescence analysis. (A) TER in control cells or HDMEC treated with inflammatory agents.
Arrows denote the application of mediators. Results are expressed as a mean ± SEM (n = 2). Mediator-
induced decrease in TER was accompanied by alterations in the immunostaining pattern not only of the
adhesion junctional protein VE-cadherin but also of α-adducin and α-adducin (pSer481). (B-E) HDMEC
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cell membranes was suggested [34, 35]. In this respect, the most important outcome of our
study is that α-adducin is required for endothelial barrier formation. Monolayers transiently
transfected with α-adducin siRNA exhibited attenuated formation of the endothelial barrier.
The same holds true for more rapid barrier reassembly, since we could show that depletion of
α-adducin led to impaired reestablishment of the endothelial barrier when monolayers were
subjected to Ca2+-switch. Our observation confirmed previously published data in colonic epi-
thelial cells demonstrating a significant delay in TER recovery in adducin-depleted cell mono-
layers subjected to Ca2+-switch [13]. Given the fact that adducins are associated with and
participate in the regulation of different cytoskeletal structures, we suggest that they may regu-
late endothelial junctions also by controlling either organization of the spectrin lattice or as-
sembly of actin filaments in areas of cell-cell contacts, as was shown in epithelial cells [12, 13].
In this regard, similar to recently published report [14], we observed that adducin silencing in-
duced disruption of the actin cytoskeleton (S3 Fig). Moreover, we found that F-actin staining
was significantly reduced when VE-cadherin homophilic binding was disturbed by Ca2+-
depletion, an effect that was also paralleled by reduced adducin staining. Therefore, further ex-
aminations should be performed to elucidate whether VE-cadherin binding regulates actin dy-
namic via adducins.
In conclusion, our study reveals a novel role of α-adducin in the regulation of endothelial
barrier integrity which at least in part may be due to α-adducin-mediated control of
AJ assembly.
Supporting Information
S1 Fig. Isotype specificity of the primary antibody. To test the isotype specificity of the pri-
mary antibody, HDMEC and MyEnd cell monolayers, handled identically as controls, were si-
multaneously immunostained with normal mouse and rabbit IgG. The latter represented the
same subclasses of α-adducin Abs which have been used in the study. DAPI staining was used
to confirm confluent cell monolayers. Besides the slight cytoplasmic staining of rabbit IgG-Cy3
in MyEnd cells, no unspecific immunosignals were detected. Scale bar = 20 μm.
(TIF)
S2 Fig. Cy-labeled antibodies are specific. To test the specificity of the secondary antibody,
different cyanine dyes (Cy)- conjugated secondary antibodies (Abs) were applied to cell mono-
layers grown under control conditions. In order to confirm confluency of the cell monolayer,
nuclei were stained directly with DAPI. None of the immunolabelings showed unspecific for
the secondary antibody staining, which indicates that the Cy-label antibodies are specific to the
respective primary antibody. Scale bar = 20 μm. dag is donkey anti-goat; garb is goat anti-
rabbit; gam is goat anti-mouse; gart is goat anti-rat.
(TIF)
S3 Fig. Adducin silencing induced disruption of the actin cytoskeleton.MyEnd monolayers
transfected with n.t siRNA and adducin-specific siRNAs were stained for α-adducin and F-
monolayers exposed to inflammatory mediators or control cells were immunostained for VE-cadherin, α-
adducin and α-adducin (pSer481). Staining for F-actin and for nuclei was also accomplished with Alexa Fluor
488 and DAPI, respectively. In comparison to control condition (B) where VE-cadherin was linearly
distributed along cell borders and α-adducin as well as α-adducin (pSer481) were present at cell-cell contacts
(arrows, B), treatment with LPS (C), thrombin (D) and TNFα (E) led to considerable intercellular gap formation
(arrowheads, C-E), paralleled by pronounced increased stress fiber formation and fragmented VE-cadherin
distribution. This effect was associated with almost complete loss of α-adducin membrane staining. No
differences in the nuclear morphology were observed under these conditions. Scale bar = 20 μm.
doi:10.1371/journal.pone.0126213.g005
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actin. (A) Under control conditions, α-adducin localized partly along cell junctions which was
accompanied with intensive F-actin staining all over the cells. (B) In contrast, α-adducin-
depleted monolayers showed reduced adducin staining at cell junctions paralleled by signifi-
cantly attenuated staining for F-actin. Scale bar = 20 μm.
(TIF)
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